Latest filing published 04 Sept 2026 for PALVELLA THERAPEUTICS, INC., €34k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -85.6%Entry US$67.84 · Close at T+365 US$9.79
- +5.9%Entry US$422.40 · Close at T+365 US$447.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher P. Kiritsy: trading record in brief
Christopher P. Kiritsy discloses dealings in Palvella Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 21 April 2017 to 2 September 2026, the count stands at 5 filings.
Both buying and selling appear: 2 purchases worth €30k, against 1 sale worth €42k. Taken together, the sales exceed the purchases by €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 4 September 2026, reports an option exercise of €34k in Palvella Therapeutics, Inc. The latest purchase dates back some time: it was published 1,260 days ago, on 30 May 2023. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Christopher P. Kiritsy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 313 shares@ US$127.200.0021% mcap30.2% of flowCommon StockSEC:0001104659-26-105494:0
- 313 shares@ US$157.000.0026% mcap37.2% of flowCommon StockSEC:0001104659-26-105494:1
- 10,000 shares@ US$0.85100.0% of flowCommon StockSEC:0001562180-23-004575:0Canonical exit: 23 Aug 2023 (T+90)
- 5,000 shares@ US$5.1120.5% of flowCommon StockSEC:0001562180-18-003953:0Canonical exit: 13 Dec 2018 (T+90)
- 5,000 shares@ US$1.596.5% of flowCommon StockSEC:0000899243-17-012544:0
5 of 5 declarations
